The Neurodegeneration Genetics Study - NI

Strand Life Sciences Private Limited0 sites0 target enrollmentTBD

ConditionsHealth Condition 1: G30- Alzheimers diseaseHealth Condition 2: G310- Frontotemporal dementiaHealth Condition 3: G31- Other degenerative diseases of nervous system, not elsewhere classifiedHealth Condition 4: G20- Parkinsons diseaseHealth Condition 5: G231- Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

Overview

Phase: 未知
Intervention: Not specified
Conditions: Health Condition 1: G30- Alzheimers diseaseHealth Condition 2: G310- Frontotemporal dementiaHealth Condition 3: G31- Other degenerative diseases of nervous system, not elsewhere classifiedHealth Condition 4: G20- Parkinsons diseaseHealth Condition 5: G231- Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
Sponsor: Strand Life Sciences Private Limited
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Observational

Investigators

Sponsor

Strand Life Sciences Private Limited

Eligibility Criteria

Inclusion Criteria

•1\.Adults aged 18 years and above
•2\.Adults capable of giving a written informed consent to participate
•3\.Individuals with confirmed diagnosis of one of the above, along with enough clinical information available (age of onset, method of diagnosis, phenotypic characteristics of the patient, information on rate of progression, clinical history)
•4\.Individuals from the general population of any ethnicity, sex and race
•5\.Ability to understand and the willingness to sign a written Informed Consent Form
•6\.Willingness to contribute 20 \- 23 ml blood
•Control Arm
•1\.Individuals with no symptoms of the disease or prior history of any of the conditions mentioned under â??study armâ??
•2\.Adults aged 50 years and above
•3\.Adults capable of giving a written informed consent to participate

Exclusion Criteria

•Study and Control Group
•1\.Subjects with symptoms of treatable dementia like dementia due to stroke, tumor in frontotemporal region, hemorrhage in brain
•2\.Subjects not consenting or unable to give an informed written consent
•3\.Subjects who have an uncontrolled infection
•4\.Individuals with any acute illness or infection
•5\.Women who are pregnant or suspect they are pregnant and lactating mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting

Not Applicable

Study of defective Generesponsible for Neurodegenerative Disease

CTRI/2017/07/009047Dr Kapaettu Satyamoorthy

Recruiting

Not Applicable

Study on neurodegenerative disorders associated with mechanical and physical burdens such as chronic traumatic encephalopathy and idiopathic normal pressure hydrocephalusCTE iNPH

JPRN-UMIN000049438Cyclotron and Radioisotope Center, Tohoku University56

Recruiting

Not Applicable

Genetic Analysis Study of Neurosurgical DiseasesCerebral aneurysms, cerebral arteriovenous malformations, epilepsy

JPRN-UMIN000045255RIKEN Center for Brain Science450

Recruiting

Not Applicable

Identifying the genetic background of neurological disorders related to the mitochondrial DNA repair pathwayHealth Condition 1: G300- Alzheimers disease with early onsetHealth Condition 2: G309- Alzheimers disease, unspecifiedHealth Condition 3: G31- Other degenerative diseases of nervous system, not elsewhere classifiedHealth Condition 4: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhere

CTRI/2024/03/063469Sanjiban Chakrabarty

Completed

Not Applicable

Clinical study for degenerative dementiaCorticobasal syndrome, Primary progressive aphasia, Dementia with Lewy bodies

JPRN-UMIN000014098Juntendo University school of Medicine Department of Diagnosis, Prevention and Treatment of Dementia150